Press releases

Cancel
  • Joint publication with the German Environment Agency (UBA) / 2025

    New study defines threshold concentration for allergic reactions to birch pollen

    News / July 17, 2025

    How many birch pollen particles in the air trigger symptoms in individuals with allergies? A recent study published in the journal International Archives of Allergy and Immunology provides an answer: allergic symptoms occur at concentrations of 50 - 100 pollen per cubic meter of air.

    more info
  • PREPARE project DUSTIN launched / 2025

    Drug-free autoimmune therapy: Fraunhofer drives ahead with selective nerve stimulation

    News / July 14, 2025

    Targeted nerve stimulation instead of drugs: With the kick-off of the PREPARE project DUSTIN, a promising research alliance for the visionary treatment of autoimmune diseases is starting its work. Four Fraunhofer Institutes are pooling their expertise to develop a miniaturized, battery-free implant that communicates and is powered by ultrasound. The project is receiving €3.5 million in funding.

    more info
  • The Pharmaceutical Biotechnology division at the Braunschweig location of the Fraunhofer Institute for Toxicology and Experimental Medicine ITEM, one of the institute’s five research divisions at three different locations, is to be closed as of February 28, 2026. The research division has been operating at an ongoing deficit, with little likelihood of this changing in the future. The executive board of the Fraunhofer-Gesellschaft has now approved the request to this effect made by the institute management. One possible solution for maintaining the Braunschweig location remains – the transfer to a private company.

    more info
  • New Approach to Measuring Drug Levels in the Lungs / 2025

    Fraunhofer ITEM Researchers Receive Willi Stahlhofen Award for their Publication

    Press Release  / June 25, 2025

    A research team from the Fraunhofer Institute for Toxicology and Experimental Medicine ITEM has, for the first time, demonstrated that drug concentrations in the human lung can be measured directly via particles in exhaled breath – a breakthrough with major implications for the targeted development and optimization of inhaled therapies. For this groundbreaking study, Prof. Dr. Jens Hohlfeld, Head of Airway Research at Fraunhofer ITEM, together with Dr. Olaf Holz, received the prestigious Willi Stahlhofen Award from the International Society for Aerosols in Medicine (ISAM). The award ceremony took place on June 24 at the ISAM Congress in Washington DC, USA.

    more info
  • Award for outstanding doctoral thesis / 2025

    Linda Steinacher receives MHH doctoral prize

    News / June 11, 2025

    Dr. Steinacher completed her doctoral studies with a dissertation conducted in collaboration between MHH, Fraunhofer ITEM, and F. Hoffmann-La Roche AG in Basel. The work was supervised by Dr. Lauriane Cabon (Roche) and Prof. Dr. Armin Braun (Fraunhofer ITEM). She was awarded one of the two doctoral prizes of the Society of Friends of MHH e.V., each worth €2,500.

    more info
  • New insights into the early steps of cancer spread in melanoma / 2025

    How do metastases form?

    News / May 16, 2025

    What drives the metastasis of melanomas right from the very beginning – long before it becomes clinically detectable? This is the question the research teams addressed in their publication in Nature Cancer.

    more info
  • Expert interview on synthetic biology / 2025

    Synthetic DNA as Mass Data Storage of the Future

    Press Release / Research News / May 05, 2025

    Traditional storage solutions are reaching their limits in light of the steadily in-creasing volume of data generated worldwide. In the BIOSYNTH project, three Fraunhofer institutes are developing a microchip platform for future mass data storage using synthetic DNA. In this interview, Dr. Uwe Vogel, the project’s co-ordinator and head of the Microdisplays and Sensors department at the Fraun-hofer Institute for Photonic Microsystems IPMS, explains how the researchers plan to widen the use of this high throughput-capable, modular system for synthesizing DNA, RNA and peptides to also include biological applications such as screening for harmful substances and development of active ingredi-ents.

    more info
  • Multicellular human cardiac organoids for drug research / 2025

    Miniature Hearts: Cardiac Organoids With an Immune System

    Press Release / Research News / May 05, 2025

    The development of novel therapeutics offer great hope for the fight against widespread diseases such as cancer, but they can impair the cardiovascular system, so development often fails early on. Researchers from the Fraunhofer Institute for Toxicology and Experimental Medicine ITEM and Hannover Medical School have developed a complex cardiac organoid model that can be used to study the potential cardiotoxicity of new medications. Their miniature heart even has an immune system of its own.

    more info